Moore Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-12,000
Closed -$4.79M – 495
2024
Q1
$4.79M Buy
+12,000
New +$4.53M 0.08% 208
2023
Q4
– Sell
-25,000
Closed -$7.31M – 492
2023
Q3
$7.31M Buy
+25,000
New +$7.81M 0.14% 121
2023
Q2
– Sell
-55,887
Closed -$14.3M – 555
2023
Q1
$14.3M Buy
55,887
+5,887
+12% +$1.45M 0.3% 65
2022
Q4
$13.3M Sell
50,000
-87,968
-64% -$21.4M 0.31% 52
2022
Q3
$25.9M Buy
137,968
+85,816
+165% +$18.4M 0.61% 32
2022
Q2
$10.5M Buy
52,152
+45,885
+732% +$10.8M 0.28% 70
2022
Q1
$1.89M Sell
6,267
-62,562
-91% -$18.3M 0.05% 385
2021
Q4
$24.7M Buy
+68,829
New +$23.7M 0.49% 37
2016
Q1
– Sell
-162,000
Closed -$9.83M – 286
2015
Q4
$9.83M Buy
+162,000
New +$9.1M 0.3% 89
2014
Q1
– Sell
-135,000
Closed -$5.76M – 497
2013
Q4
$5.76M Buy
+135,000
New +$5.68M 0.09% 182

Other funds holding ISRG

Moore Capital Management's ISRG Position: Q2 2024 in Review

Moore Capital Management sold out of Intuitive Surgical (ISRG) in Q2 2024, closing a stake of 12,000 shares — an estimated $4.79M sold.

Moore Capital Management first reported a position in ISRG in Q4 2013 and held it in 10 quarters. The position peaked at $25.9M in Q3 2022. 1,824 funds tracked by Wall St. Rank hold ISRG as of Q2 2024.

  • Moore Capital Management reported no remaining Intuitive Surgical position as of Q2 2024 after selling out during the quarter.
  • Moore Capital Management sold 12,000 Intuitive Surgical shares in Q2 2024, an estimated $4.79M.
  • Moore Capital Management first reported a position in Intuitive Surgical in Q4 2013 and held it in 10 quarters.
  • Moore Capital Management's Intuitive Surgical position peaked at $25.9M in Q3 2022.
  • 1,824 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2024.

Based on Moore Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.